N-[4-[(3S)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;N-[4-[(3R)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;2-(1,3-dihydropyrrolo[3,4-c]pyridin-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(5,6-dimethoxy-1,3-dihydroisoindol-2-yl)-6-oxo-N-(4-piperazin-1-yl-3-pyridinyl)-1H-pyrimidine-4-carboxamide;2-(5-fluoro-1,3-dihydroisoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide
C111H115FN38O8 — CID 158215123
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[(3S)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;N-[4-[(3R)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;2-(1,3-dihydropyrrolo[3,4-c]pyridin-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(5,6-dimethoxy-1,3-dihydroisoindol-2-yl)-6-oxo-N-(4-piperazin-1-yl-3-pyridinyl)-1H-pyrimidine-4-carboxamide;2-(5-fluoro-1,3-dihydroisoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide
N-[4-[(3S)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;N-[4-[(3R)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;2-(1,3-dihydropyrrolo[3,4-c]pyridin-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(5,6-dimethoxy-1,3-dihydroisoindol-2-yl)-6-oxo-N-(4-piperazin-1-yl-3-pyridinyl)-1H-pyrimidine-4-carboxamide;2-(5-fluoro-1,3-dihydroisoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide (PubChem CID 158215123) has the molecular formula C111H115FN38O8 and a molecular weight of 2128.40 g/mol. Its IUPAC name is N-[4-[(3S)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;N-[4-[(3R)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;2-(1,3-dihydropyrrolo[3,4-c]pyridin-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(5,6-dimethoxy-1,3-dihydroisoindol-2-yl)-6-oxo-N-(4-piperazin-1-yl-3-pyridinyl)-1H-pyrimidine-4-carboxamide;2-(5-fluoro-1,3-dihydroisoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide.
Molecular Properties
| Compound Name | N-[4-[(3S)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;N-[4-[(3R)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;2-(1,3-dihydropyrrolo[3,4-c]pyridin-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(5,6-dimethoxy-1,3-dihydroisoindol-2-yl)-6-oxo-N-(4-piperazin-1-yl-3-pyridinyl)-1H-pyrimidine-4-carboxamide;2-(5-fluoro-1,3-dihydroisoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide |
|---|---|
| PubChem CID | 158215123 |
| Molecular Formula | C111H115FN38O8 |
| Molecular Weight | 2128.40 g/mol |
| Exact Mass | 2126.97 |
| IUPAC Name | N-[4-[(3S)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;N-[4-[(3R)-3-aminopiperidin-1-yl]-3-pyridinyl]-2-indazol-1-ylpyrimidine-4-carboxamide;2-(1,3-dihydropyrrolo[3,4-c]pyridin-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(5,6-dimethoxy-1,3-dihydroisoindol-2-yl)-6-oxo-N-(4-piperazin-1-yl-3-pyridinyl)-1H-pyrimidine-4-carboxamide;2-(5-fluoro-1,3-dihydroisoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide |
| SMILES | COc1cc2c(cc1OC)CN(c1nc(C(=O)Nc3cnccc3N3CCNCC3)cc(=O)[nH]1)C2.N[C@@H]1CCCN(c2ccncc2NC(=O)c2ccnc(-n3ncc4ccccc43)n2)C1.N[C@H]1CCCN(c2ccncc2NC(=O)c2ccnc(-n3ncc4ccccc43)n2)C1.O=C(Nc1cnccc1N1CCNCC1)c1ccnc(N2Cc3ccc(F)cc3C2)n1.O=C(Nc1cnccc1N1CCNCC1)c1ccnc(N2Cc3ccncc3C2)n1 |
| InChI | InChI=1S/C24H27N7O4.C22H22FN7O.2C22H22N8O.C21H22N8O/c1-34-20-9-15-13-31(14-16(15)10-21(20)35-2)24-28-17(11-22(32)29-24)23(33)27-18-12-26-4-3-19(18)30-7-5-25-6-8-30;23-17-2-1-15-13-30(14-16(15)11-17)22-26-6-3-18(28-22)21(31)27-19-12-25-5-4-20(19)29-9-7-24-8-10-29;2*23-16-5-3-11-29(14-16)20-8-9-24-13-18(20)27-21(31)17-7-10-25-22(28-17)30-19-6-2-1-4-15(19)12-26-30;30-20(26-18-12-24-5-3-19(18)28-9-7-22-8-10-28)17-2-6-25-21(27-17)29-13-15-1-4-23-11-16(15)14-29/h3-4,9-12,25H,5-8,13-14H2,1-2H3,(H,27,33)(H,28,29,32);1-6,11-12,24H,7-10,13-14H2,(H,27,31);2*1-2,4,6-10,12-13,16H,3,5,11,14,23H2,(H,27,31);1-6,11-12,22H,7-10,13-14H2,(H,26,30)/t;;2*16-;/m..10./s1 |
| InChIKey | GCOBXAUYIWCOHE-ILXICOIMSA-N |
| XLogP | 9.79 |
| TPSA | 539.86 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 158 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2128.40 |
| LogP ≤ 5 | 9.79 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 40 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158215123 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.